ADPT
Adaptive Biotechnologies Corp
27.90$
-2.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -90.7% | -58.0% | 241.5% | -152.1% | -124.9% | -99.3% | -91.8% | -53.2% | -16.6% | |
| 15.1% | 10.8% | 9.2% | 8.6% | 13.6% | 15.2% | 13.1% | 10.8% | 6.4% | |
| 18.2% | 20.0% | 15.4% | 25.2% | 28.0% | 29.9% | 36.9% | 30.0% | 18.6% | |
| 19.9% | 17.8% | 13.3% | 25.2% | 28.0% | 30.5% | – | – | – | |
| -14.2% | -3.1% | 299.7% | -41.5% | -36.8% | -38.6% | -27.1% | -9.8% | -20.9% | |
| 6.5% | 11.4% | 13.2% | 19.1% | 40.0% | 8.8% | 6.3% | 2.0% | 1.1% | |
| 94.8% | 1.3% | -566.2% | -119.0% | 117.4% | 1.6% | 76.1% | 43.5% | 13.7% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 130.2% | 2.3% | 381.9% | 298.4% | 17.3% | 4.3% | – | – | – | |
| 0.0% | 0.0% | – | – | 0.0% | 67.1% | – | – | – | |
| 130.1% | 2.2% | 376.1% | 298.4% | 17.6% | 71.4% | 1.3% | 0.1% | 11.0% | |
| 134.2% | -54.4% | 51.3% | 27.3% | 10.1% | -26.5% | -14.7% | -9.6% | 8.1% | |
| -97.2% | -69.3% | 228.3% | -171.3% | -164.9% | -108.1% | -98.1% | -55.3% | -17.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.